Clinical Trials Browser

Has results × dalotuzumab × Thoracic × Clear all

NCT00654420 2018-08-08

A Study Evaluating Dalotuzumab (MK-0646) in Combination With Erlotinib for Participants With Non-Small Cell Lung Cancer (MK-0646-007)

Phase 2 Completed

95 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung